Matrix Metalloproteinase Inhibitors and Cancer

This publication has 50 references indexed in Scilit:

• Identification and Structural and Functional Characterization of Human Enamelysin (MMP-20)^,
  Biochemistry, 1997
• Matrix Metalloproteinases
  Drugs & Aging, 1997
• Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
  European Journal Of Cancer, 1996
• Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase a
  International Journal of Cancer, 1995
• Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic Mice
  JNCI Journal of the National Cancer Institute, 1995
• Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancer
  Cancer, 1995
• Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer
  International Journal of Cancer, 1995
• Cell surface binding of TIMP‐2 and pro‐MMP‐2/TIMP‐2 complex
  FEBS Letters, 1995
• Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
  International Journal of Cancer, 1994
• Inhibition of collagenolytic activity relates to quantitative reduction of invasionin vitro in a c-Ha-ras transfected glial cell line
  Journal of Neuro-Oncology, 1994